Drug target validation of the enterovirus D68 2A protease
$540,570R01FY2021AINIH
Rutgers, The State Univ Of N.J., New Brunswick NJ
Investigators
Linked publications, trials & patents
Paper 38565852Paper 37154751Paper 36580641Paper 36119652Paper 36060104Paper 35578732Paper 35474901Paper 35404564Paper 35378761Paper 35292745Paper 35284599Paper 35178512Paper 35080027Paper 34860011Paper 34745850Paper 34427541Paper 33953295Paper 33891389Paper 33645977Paper 33568498Paper 33560940Paper 33330841Paper 33158912Paper 33140049Paper 32692536Paper 32559580Paper 32541865Paper 32352280Patent 11866407Patent 11834451
View original record on NIH RePORTER →